FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:INPP5A-FAM149B1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: INPP5A-FAM149B1
FusionPDB ID: 39806
FusionGDB2.0 ID: 39806
HgeneTgene
Gene symbol

INPP5A

FAM149B1

Gene ID

3632

317662

Gene nameinositol polyphosphate-5-phosphatase Afamily with sequence similarity 149 member B1
Synonyms5PTASEJBTS36|KIAA0974
Cytomap

10q26.3

10q22.2

Type of geneprotein-codingprotein-coding
Descriptioninositol polyphosphate-5-phosphatase A43 kDa inositol polyphosphate 5-phophatase43 kDa inositol polyphosphate 5-phosphataseCTCL tumor antigen HD-CL-02InsP3 5-phosphataseinositol polyphosphate-5-phosphatase, 40kDinositol polyphosphate-5-phosphatase, protein FAM149B1
Modification date2020031320200313
UniProtAcc

Q14642

Main function of 5'-partner protein: FUNCTION: Phosphatase that specifically hydrolyzes the 5-phosphate of inositol 1,4,5-trisphosphate to inositol 1,4-bisphosphate, and inositol 1,3,4,5-tetrasphosphate to inositol 1,3,4-trisphosphate (PubMed:8013665, PubMed:8769125, PubMed:8626616). Plays a crucial role in the survival of cerebellar Purkinje cells (By similarity). {ECO:0000250|UniProtKB:Q7TNC9, ECO:0000269|PubMed:8013665, ECO:0000269|PubMed:8626616, ECO:0000269|PubMed:8769125}.

Q96BN6

Main function of 5'-partner protein: FUNCTION: Involved in the localization of proteins to the cilium and cilium assembly. Indirectly regulates the signaling functions of the cilium, being required for normal SHH/smoothened signaling and proper development. {ECO:0000269|PubMed:30905400}.
Ensembl transtripts involved in fusion geneENST idsENST00000368593, ENST00000368594, 
ENST00000487614, 
ENST00000607940, 
ENST00000242505, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score21 X 9 X 11=20797 X 9 X 5=315
# samples 219
** MAII scorelog2(21/2079*10)=-3.30742852519225
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(9/315*10)=-1.8073549220576
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: INPP5A [Title/Abstract] AND FAM149B1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: INPP5A [Title/Abstract] AND FAM149B1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)INPP5A(134563349)-FAM149B1(74999070), # samples:3
Anticipated loss of major functional domain due to fusion event.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneINPP5A

GO:0046855

inositol phosphate dephosphorylation

8006039



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr10:134563349/chr10:74999070)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across INPP5A (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across FAM149B1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000368594INPP5Achr10134563349+ENST00000242505FAM149B1chr1074999070+481211802771326349
ENST00000368593INPP5Achr10134563349+ENST00000242505FAM149B1chr1074999070+478311512481297349
ENST00000368594INPP5Achr10134563349+ENST00000242505FAM149B1chr1074999069+481211802771326349
ENST00000368593INPP5Achr10134563349+ENST00000242505FAM149B1chr1074999069+478311512481297349

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000368594ENST00000242505INPP5Achr10134563349+FAM149B1chr1074999070+0.0010187780.9989812
ENST00000368593ENST00000242505INPP5Achr10134563349+FAM149B1chr1074999070+0.0010082630.9989918
ENST00000368594ENST00000242505INPP5Achr10134563349+FAM149B1chr1074999069+0.0010187780.9989812
ENST00000368593ENST00000242505INPP5Achr10134563349+FAM149B1chr1074999069+0.0010082630.9989918

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for INPP5A-FAM149B1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
INPP5Achr10134563349FAM149B1chr10749990691151301FNQEVFRDNNGTALDTQYRRSCAVEY
INPP5Achr10134563349FAM149B1chr10749990691180301FNQEVFRDNNGTALDTQYRRSCAVEY
INPP5Achr10134563349FAM149B1chr10749990701151301FNQEVFRDNNGTALDTQYRRSCAVEY
INPP5Achr10134563349FAM149B1chr10749990701180301FNQEVFRDNNGTALDTQYRRSCAVEY

Top

Potential FusionNeoAntigen Information of INPP5A-FAM149B1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
INPP5A-FAM149B1_134563349_74999069.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:01FRDNNGTAL0.99880.8707514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B38:02FRDNNGTAL0.99660.9449514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:13FRDNNGTAL0.99650.9131514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:06FRDNNGTAL0.99570.7223514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B38:01FRDNNGTAL0.99560.9385514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B15:10FRDNNGTAL0.98540.5233514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B14:01FRDNNGTAL0.97790.5932514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B14:02FRDNNGTAL0.97790.5932514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B27:04FRDNNGTAL0.96060.6687514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B15:18FRDNNGTAL0.87930.7132514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B15:37FRDNNGTAL0.84930.6525514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-A31:02TALDTQYRR0.82770.52941120
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-A74:03GTALDTQYRR0.92960.67951020
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-A74:09GTALDTQYRR0.92960.67951020
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-A74:11GTALDTQYRR0.92960.67951020
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-A31:06GTALDTQYRR0.90840.54491020
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:01VFRDNNGTAL0.60380.8304414
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:01EVFRDNNGTAL0.84890.7731314
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:08RDNNGTAL0.86710.8426614
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:09FRDNNGTAL0.99880.5191514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:12FRDNNGTAL0.99840.8798514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C08:15FRDNNGTAL0.9960.9402514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:05FRDNNGTAL0.9960.86514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C04:10FRDNNGTAL0.98870.6692514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C04:07FRDNNGTAL0.98620.6795514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C08:03FRDNNGTAL0.97870.9749514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C07:29FRDNNGTAL0.97640.9002514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C07:05FRDNNGTAL0.97630.9194514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C07:13FRDNNGTAL0.97380.7795514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C07:27FRDNNGTAL0.97290.8905514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C07:95FRDNNGTAL0.95830.6205514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C07:46FRDNNGTAL0.93360.7235514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:08FRDNNGTAL0.89770.752514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C07:80FRDNNGTAL0.83060.8294514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C07:67FRDNNGTAL0.83060.8294514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C07:10FRDNNGTAL0.81250.8715514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C07:19FRDNNGTAL0.79820.5503514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B73:01FRDNNGTAL0.68350.5104514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B14:03FRDNNGTAL0.68060.7737514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C04:14FRDNNGTAL0.56580.7087514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C12:16FRDNNGTAL0.05390.9604514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C04:10VFRDNNGTAL0.98680.7156414
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C04:07VFRDNNGTAL0.98350.7237414
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C04:14VFRDNNGTAL0.88780.7372414
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:09VFRDNNGTAL0.71640.5322414
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:09EVFRDNNGTAL0.92780.5037314
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:12EVFRDNNGTAL0.80050.7767314
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:05EVFRDNNGTAL0.5810.7529314
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:02FRDNNGTAL0.99870.9081514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:31FRDNNGTAL0.99870.8719514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C08:02FRDNNGTAL0.9960.9402514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B38:05FRDNNGTAL0.99560.9385514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C18:01FRDNNGTAL0.99280.6996514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C04:01FRDNNGTAL0.98620.6795514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C08:01FRDNNGTAL0.97870.9749514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B27:06FRDNNGTAL0.97790.6348514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B27:09FRDNNGTAL0.97150.8378514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:11FRDNNGTAL0.95570.6909514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C03:67FRDNNGTAL0.95410.9759514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C07:01FRDNNGTAL0.94870.5625514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C07:17FRDNNGTAL0.94390.9556514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B27:08FRDNNGTAL0.92480.7123514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C07:04FRDNNGTAL0.8620.8729514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C07:02FRDNNGTAL0.83060.8294514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C07:22FRDNNGTAL0.7820.7041514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C06:08FRDNNGTAL0.72910.9883514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C06:06FRDNNGTAL0.71470.9881514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C04:04FRDNNGTAL0.67070.7483514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B07:13FRDNNGTAL0.18370.7605514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C06:02FRDNNGTAL0.08340.9932514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C06:17FRDNNGTAL0.08340.9932514
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C04:03VFRDNNGTAL0.98770.777414
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C04:01VFRDNNGTAL0.98350.7237414
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C14:03VFRDNNGTAL0.97770.9209414
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C14:02VFRDNNGTAL0.97770.9209414
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C18:01VFRDNNGTAL0.97720.7401414
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-A74:01GTALDTQYRR0.92960.67951020
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-C04:04VFRDNNGTAL0.73660.8541414
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:11VFRDNNGTAL0.64490.6881414
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:31EVFRDNNGTAL0.84350.7705314
INPP5A-FAM149B1chr10134563349chr10749990691151HLA-B39:11EVFRDNNGTAL0.82040.686314

Top

Potential FusionNeoAntigen Information of INPP5A-FAM149B1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
INPP5A-FAM149B1_134563349_74999069.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
INPP5A-FAM149B1chr10134563349chr10749990691151DRB1-0338QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB1-0338NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB1-0413NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB1-0422NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB1-0422FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB1-0472NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0109QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0109NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0109FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0202QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0202NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0202FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0202EVFRDNNGTALDTQY318
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0205QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0205NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0205FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0209QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0209NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0209FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0209EVFRDNNGTALDTQY318
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0210QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0210NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0210FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0210EVFRDNNGTALDTQY318
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0211QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0211NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0211FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0211EVFRDNNGTALDTQY318
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0212QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0212NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0212FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0212EVFRDNNGTALDTQY318
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0213QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0213NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0213FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0213EVFRDNNGTALDTQY318
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0214QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0214NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0214FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0215QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0215NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0215FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0215EVFRDNNGTALDTQY318
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0216QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0216NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0216FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0216EVFRDNNGTALDTQY318
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0217QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0217NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0217FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0218QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0218NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0218FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0218EVFRDNNGTALDTQY318
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0219QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0219NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0219FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0219EVFRDNNGTALDTQY318
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0220QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0220NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0220FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0220EVFRDNNGTALDTQY318
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0221QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0221NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0221FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0221EVFRDNNGTALDTQY318
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0222QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0222NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0222FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0222EVFRDNNGTALDTQY318
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0223QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0223NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0223FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0223EVFRDNNGTALDTQY318
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0225QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0225NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0225FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0225EVFRDNNGTALDTQY318
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0303QEVFRDNNGTALDTQ217
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0303NQEVFRDNNGTALDT116
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0303FNQEVFRDNNGTALD015
INPP5A-FAM149B1chr10134563349chr10749990691151DRB3-0303EVFRDNNGTALDTQY318

Top

Fusion breakpoint peptide structures of INPP5A-FAM149B1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
7741RDNNGTALDTQYRRINPP5AFAM149B1chr10134563349chr10749990691151

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of INPP5A-FAM149B1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN7741RDNNGTALDTQYRR-7.15543-7.26883
HLA-B14:023BVN7741RDNNGTALDTQYRR-4.77435-5.80965
HLA-B52:013W397741RDNNGTALDTQYRR-6.80875-6.92215
HLA-B52:013W397741RDNNGTALDTQYRR-4.20386-5.23916
HLA-A11:014UQ27741RDNNGTALDTQYRR-7.5194-8.5547
HLA-A11:014UQ27741RDNNGTALDTQYRR-6.9601-7.0735
HLA-A24:025HGA7741RDNNGTALDTQYRR-7.52403-7.63743
HLA-A24:025HGA7741RDNNGTALDTQYRR-5.82433-6.85963
HLA-B27:056PYJ7741RDNNGTALDTQYRR-3.28285-4.31815
HLA-B44:053DX87741RDNNGTALDTQYRR-5.91172-6.94702
HLA-B44:053DX87741RDNNGTALDTQYRR-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of INPP5A-FAM149B1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
INPP5A-FAM149B1chr10134563349chr10749990691020GTALDTQYRRGGCACCGCGCTGGATACACAGTATCGTCGC
INPP5A-FAM149B1chr10134563349chr10749990691120TALDTQYRRACCGCGCTGGATACACAGTATCGTCGC
INPP5A-FAM149B1chr10134563349chr1074999069314EVFRDNNGTALGAGGTTTTCCGAGACAACAACGGCACCGCGCTG
INPP5A-FAM149B1chr10134563349chr1074999069414VFRDNNGTALGTTTTCCGAGACAACAACGGCACCGCGCTG
INPP5A-FAM149B1chr10134563349chr1074999069514FRDNNGTALTTCCGAGACAACAACGGCACCGCGCTG
INPP5A-FAM149B1chr10134563349chr1074999069614RDNNGTALCGAGACAACAACGGCACCGCGCTG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
INPP5A-FAM149B1chr10134563349chr1074999069015FNQEVFRDNNGTALDTTCAACCAGGAGGTTTTCCGAGACAACAACGGCACCGCGCTGGAT
INPP5A-FAM149B1chr10134563349chr1074999069116NQEVFRDNNGTALDTAACCAGGAGGTTTTCCGAGACAACAACGGCACCGCGCTGGATACA
INPP5A-FAM149B1chr10134563349chr1074999069217QEVFRDNNGTALDTQCAGGAGGTTTTCCGAGACAACAACGGCACCGCGCTGGATACACAG
INPP5A-FAM149B1chr10134563349chr1074999069318EVFRDNNGTALDTQYGAGGTTTTCCGAGACAACAACGGCACCGCGCTGGATACACAGTAT

Top

Information of the samples that have these potential fusion neoantigens of INPP5A-FAM149B1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BRCAINPP5A-FAM149B1chr10134563349ENST00000368593chr1074999069ENST00000242505TCGA-AO-A03P

Top

Potential target of CAR-T therapy development for INPP5A-FAM149B1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to INPP5A-FAM149B1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to INPP5A-FAM149B1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource